Pharmaniaga Bhd (XKLS:7081) Cash-to-Debt : 0.05 (As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Pharmaniaga Bhd Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Pharmaniaga Bhd's cash to debt ratio for the quarter that ended in Sep. 2024 was 0.05.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Pharmaniaga Bhd couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

The historical rank and industry rank for Pharmaniaga Bhd's Cash-to-Debt or its related term are showing as below:

XKLS:7081' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02 Med: 0.05 Max: 0.16
Current: 0.05

During the past 13 years, Pharmaniaga Bhd's highest Cash to Debt Ratio was 0.16. The lowest was 0.02. And the median was 0.05.

XKLS:7081's Cash-to-Debt is ranked worse than
91.74% of 109 companies
in the Medical Distribution industry
Industry Median: 0.79 vs XKLS:7081: 0.05

Pharmaniaga Bhd Cash-to-Debt Historical Data

The historical data trend for Pharmaniaga Bhd's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Pharmaniaga Bhd Cash-to-Debt Chart

Pharmaniaga Bhd Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.05

0.06

0.05

0.11

Pharmaniaga Bhd Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial															0.03	0.11	0.07	0.06	0.05

Competitive Comparison of Pharmaniaga Bhd's Cash-to-Debt

For the Medical Distribution subindustry, Pharmaniaga Bhd's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaniaga Bhd's Cash-to-Debt Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's Cash-to-Debt falls into.

Pharmaniaga Bhd Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Pharmaniaga Bhd's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	127.441	/	(1051.67	+	139.713)
	=	0.11

Pharmaniaga Bhd's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	66.428	/	(1123.01	+	115.702)
	=	0.05

Pharmaniaga Bhd (XKLS:7081) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Pharmaniaga Bhd Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Pharmaniaga Bhd's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaniaga Bhd Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Pharmaniaga Bhd (XKLS:7081) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, Shah Alam, SGR, MYS, 40000

Website

https://www.pharmaniaga.com

Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices, sales and marketing as well as the distribution of medical products and hospital equipment. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing, and Indonesia. Maximum revenue is generated by the logistics and distribution segment. It derives revenue from Malaysia, Indonesia, and Other countries, of which key revenue is derived from Malaysia.

Pharmaniaga Bhd Headlines

No Headlines